Sumitomo Mitsui Trust Group Inc. Has $38.76 Million Stock Holdings in National Health Investors, Inc. (NYSE:NHI)

Sumitomo Mitsui Trust Group Inc. trimmed its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 2.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 461,124 shares of the real estate investment trust's stock after selling 11,835 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 1.06% of National Health Investors worth $38,762,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Jupiter Asset Management Ltd. increased its holdings in shares of National Health Investors by 448.7% in the first quarter. Jupiter Asset Management Ltd. now owns 76,875 shares of the real estate investment trust's stock worth $4,830,000 after acquiring an additional 62,865 shares in the last quarter. Strategic Financial Concepts LLC bought a new stake in National Health Investors during the 2nd quarter worth approximately $28,000. Russell Investments Group Ltd. raised its holdings in National Health Investors by 733.8% during the 1st quarter. Russell Investments Group Ltd. now owns 53,783 shares of the real estate investment trust's stock worth $3,379,000 after buying an additional 47,333 shares during the period. Acadian Asset Management LLC bought a new position in National Health Investors in the second quarter valued at approximately $457,000. Finally, LSV Asset Management boosted its holdings in shares of National Health Investors by 3.7% in the second quarter. LSV Asset Management now owns 131,400 shares of the real estate investment trust's stock valued at $8,900,000 after buying an additional 4,700 shares during the period. Institutional investors own 62.51% of the company's stock.

National Health Investors Stock Up 0.5 %

NYSE:NHI opened at $77.74 on Friday. National Health Investors, Inc. has a twelve month low of $51.59 and a twelve month high of $86.13. The firm has a market capitalization of $3.53 billion, a price-to-earnings ratio of 26.71, a price-to-earnings-growth ratio of 5.19 and a beta of 1.05. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock's 50 day moving average price is $80.08 and its two-hundred day moving average price is $73.98.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business's revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.08 EPS. Equities research analysts expect that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.63%. National Health Investors's dividend payout ratio is 123.71%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on NHI shares. Truist Financial raised their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 30th. Bank of America initiated coverage on National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price target on the stock. StockNews.com downgraded National Health Investors from a "buy" rating to a "hold" rating in a report on Tuesday, October 15th. Finally, Wells Fargo & Company lowered National Health Investors from an "overweight" rating to an "equal weight" rating and lifted their target price for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.